TheraRadar
Data updated: May 26, 2026

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (amlodipine besylate)

Cardiovascular Approved 2007-05-18

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is indicated for the treatment of Hypertension.

Source: FDA Label • CHARTWELL RX

How AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Works

This combination medication lowers blood pressure through two synergistic pathways. Benazepril, an ACE inhibitor, prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor; this results in decreased vasopressor activity and reduced aldosterone secretion. Amlodipine, a dihydropyridine calcium channel blocker, inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, resulting in peripheral arterial vasodilation and decreased systemic vascular resistance. Together, these mechanisms reduce blood pressure more effectively than either component alone.

Source: FDA Label
10
Indications
--
Phase 3 Trials
19
Years on Market

Details

Status
Discontinued
First Approved
2007-05-18
Routes
ORAL
Dosage Forms
CAPSULE

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Approval History

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
426 FDA actions from 2007 to 2023
Dec 2023 SUPPL
Label · Labeling
Apr 2023 SUPPL
Label · Labeling
Mar 2023 SUPPL
Label · Labeling

What AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Treats

1 indications

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is approved for 1 conditions since its original approval in 2007. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypertension
Source: FDA Label

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Boxed Warning

FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride capsules as soon as possible ( 5.5 ). Drugs that act directly on the renin-angiotensin system (RAS) can cause injury and death to the developing fetus ( 5.5 ) WARNING: FETAL TOXICITY When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride capsules as soon as possible ( 5.5 ). Drugs that act directly on the renin-angiot...

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 16 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACEBUTOLOL HYDROCHLORIDE
ACEBUTOLOL HYDROCHLORIDE
1 shared
PHARMOBEDIENT
Shared indications:
ALDACTONE
SPIRONOLACTONE
1 shared
Pfizer
Shared indications:
ALISKIREN HEMIFUMARATE
ALISKIREN HEMIFUMARATE
1 shared
PH HEALTH
Shared indications:
📋

Clinical Trial Registry

8 trials
Trial Sponsor ID Phase Status Title
NCT04434664 BLOCK HFpEF results posted 833517 Ph 4 completed BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
NCT04974138 CSPPT2-CC/CT CSPPT2-CC/CT_2020 Ph 4 recruiting China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
NCT04974151 CSPPT2-TT CSPPT2-TT_2020 Ph 4 recruiting China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
NCT05275907 STU00215781 1R56HL155093-01 Ph 4 withdrawn Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
NCT02940548 NARRAS 2016PHB013-02 Ph 4 terminated Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness
NCT01302691 results posted 0954E-357 Ph 3 completed MK-0954E Study in Participants With Hypertension (MK-0954E-357)
NCT02353806 results posted 042014-059 UL1TR001105 Ph 4 completed Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
NCT01556997 PATH results posted X985400 Ph 3 completed Perindopril Amlodipine for the Treatment of Hypertension
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE FDA Label Details

Indications & Usage

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is indicated for the treatment of Hypertension.

⚠️ BOXED WARNING

WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride capsules as soon as possible ( 5.5 ). Drugs that act directly on the renin-angiotensin system (RAS) can cause injury and death to the d...

Track AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.